MiniMed Group, Inc. (MMED) stock
Close on Nov 16, 2026Market cap $5.25BP/E –Yield –
MiniMed Group, Inc. grew revenue 14.3% to $3.10B over the twelve months to Apr 24, 2026. Free cash flow was -$420.00M. At the latest close the market valued the company at $5.25B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 31, 2026
Valuation
- Market cap
- $5.25B
- P/E ratio
- –
- Price to sales
- 1.69
- Price to book
- 1.45
- Dividend yield
- –
- Free cash flow yield
- -8.00%
Fundamentals
- Revenue
- $3.10B
- Net income
- -$333.00M
- EPS, diluted
- -$1.30
- Free cash flow
- -$420.00M
- Book value per share
- $12.88
- Diluted shares
- 281M
Trading
- Previous close
- $17.99
- Open
- $18.83
- Day's range
- $18.46 – $19.11
- Volume
- 10,719,690
- Average volume (20 days)
- 7,609,942
- Index membership
- Russell 2000 (since Jun 2026)
- RSI (14 days)
- 50.9
- Volatility (1 year)
- 57.8%
- Relative volume
- 1.76×
On 1 of our idea list: Institutions accumulating
Index membership is inferred from the holdings of funds that track each index (IWM), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 16, 2026. The S&P 500 is measured by the SPY fund.
| Period | MMED | S&P 500 | Difference | MMED per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +6.6% | -3.1% | +9.7 pts | ||
| 3 months | -7.4% | -4.5% | −3.0 pts | ||
| Year to date | +62066.7% | +9.4% | +62057.3 pts | ||
| 1 year | +62066.7% | +11.3% | +62055.4 pts | ||
| 3 years | +62066.7% | +70.4% | +61996.3 pts | +753.5% | +19.4% |
| 5 years | +62066.7% | +68.6% | +61998.1 pts | +262.0% | +11.0% |
| 10 years | +62066.7% | +297.7% | +61769.0 pts | +90.3% | +14.8% |
Four years at a glance
Fiscal years 2023 to 2026, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases MiniMed filed with the SEC as exhibits to Form 8-K or 6-K
About MiniMed
Surgical & Medical Instruments & Apparatus
MiniMed Group, Inc. develops, manufactures, and sells medical technologies for diabetes care. Its primary offerings comprise automated insulin delivery systems, smart multiple daily injection devices, continuous glucose monitoring sensors, smart insulin pens, and consumable supplies like infusion sets and reservoirs. The company also provides therapy management software and mobile applications that coordinate glucose sensing with algorithmic insulin dosing. MiniMed provides these solutions to people with type 1 and type 2 diabetes requiring intensive insulin treatment, reaching patients through durable medical equipment providers and retail pharmacies upon prescription from healthcare professionals.
Company profile, executives and historyMiniMed stock: common questions
What is MiniMed's stock price?
MMED closed at $18.65 on Nov 16, 2026, up 3.67% on the day.
What is MiniMed's market cap?
MiniMed was worth $5.25B at the close on Nov 16, 2026: the share price times the diluted shares outstanding.
What is MMED's P/E ratio?
MiniMed lost money over the twelve months to Apr 24, 2026 (diluted EPS -$1.30), so it has no meaningful P/E ratio.
How much revenue does MiniMed make?
MiniMed reported revenue of $3.10B for the twelve months to Apr 24, 2026, up 14.3% from a year earlier.
Does MiniMed pay a dividend?
No. MiniMed has not paid a cash dividend over the last twelve months.
How has MMED stock performed over the past year?
Including dividends, MMED returned +62066.7% over the past year, against +11.3% for the S&P 500.
How many MMED shares are sold short?
10M shares were sold short at the latest FINRA report, 37.18% of the float, or 1.0 days of average trading volume.
Who are MiniMed's competitors?
Companies most similar to MiniMed by business, industry and size include PODD, TNDM, DXCM, ICUI, GMED.
See a number that looks wrong?